A Remarkable New Nutrient for Bone and Joint Health, Part 1

Cyplexinol (Ostinol) is an oral Bone Morphogenetic Protein (BMP). It signals mesenchymal stem cells to differentiate into osteoblasts, the cells that build bone. James Scaffidi, CEO and founder of Zycal Bioceuticals, details the research behind Ostinol. How does it bypass the GI tract to deliver bone benefits? How does it promote healing of fractures? What’s the evidence that it’s beneficial for osteoporosis? Do studies support its use for osteoarthritis pain? Do its benefits extend to rheumatoid arthritis? What’s the optimal dosage of Ostinol? How long before users see results? Is it compatible with other bone-building or anti-inflammatory supplements? What about osteoporosis medications? What additional conditions are being explored as targets for Ostinol? Why is it that mainstream doctors haven’t yet embraced this therapy? Click HERE for part 2.